Thomas Fleischer

16PUBLICATIONS
54CO-AUTHORS
Molecular targetsPredictive and prognostic markersStatistical and quantitative geneticsLasers and quantum electronicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 18, 2024
Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation.

Jørgen Ankill, Zhi Zhao, Xavier Tekpli

|Apr 27, 2024
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Thomas Fleischer, Mads Haugland Haugen, Jørgen Ankill

|Mar 15, 2024
Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.

Anastasia Brativnyk, Jørgen Ankill, Åslaug Helland

|Sep 28, 2023
MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.

Torgeir Mo, Siri Helene Bertelsen Brandal, Oliver Marcel Geier

|Feb 25, 2023
ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines.

Petr Daniel, Kamila Balušíková, Radka Václavíková

|Dec 23, 2022
Transcriptomic pan-cancer analysis using rank-based Bayesian inference.

Valeria Vitelli, Thomas Fleischer, Jørgen Ankill

Pageof 3

Frequent Collaborators

6 joint publications

Jørgen Ankill

4 joint publications

Anthony Mathelier

3 joint publications

Xavier Tekpli

3 joint publications

Miriam Ragle Aure